Level Four Advisory Services LLC Decreases Position in STERIS plc (NYSE:STE)

Level Four Advisory Services LLC trimmed its holdings in shares of STERIS plc (NYSE:STE) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,454 shares of the medical equipment provider’s stock after selling 56 shares during the period. Level Four Advisory Services LLC’s holdings in STERIS were worth $504,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Avalon Trust Co bought a new stake in shares of STERIS in the 4th quarter valued at about $30,000. Human Investing LLC purchased a new position in STERIS in the 4th quarter worth approximately $31,000. Anfield Capital Management LLC lifted its position in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 91 shares during the last quarter. Central Pacific Bank Trust Division boosted its stake in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 76 shares during the period. Finally, Manchester Capital Management LLC grew its holdings in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 137 shares during the last quarter. 94.69% of the stock is owned by institutional investors.

STERIS Trading Up 1.9 %

NYSE:STE opened at $227.14 on Tuesday. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $222.86 and a 200-day moving average price of $221.01. The stock has a market cap of $22.32 billion, a price-to-earnings ratio of 48.22 and a beta of 0.92.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.00%. STERIS’s payout ratio is 48.41%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Stephens reissued an “overweight” rating and set a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. JMP Securities reissued a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.